104 related articles for article (PubMed ID: 20647217)
1. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Richart C; Auguet T; Terra X
N Engl J Med; 2010 Jul; 363(2):193-4; author reply 195. PubMed ID: 20647217
[No Abstract] [Full Text] [Related]
2. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Salamone F; Galvano F; Li Volti G
N Engl J Med; 2010 Jul; 363(2):194-5; author reply 195. PubMed ID: 20653078
[No Abstract] [Full Text] [Related]
3. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Valenti L; Nobili V; Fargion S
N Engl J Med; 2010 Jul; 363(2):194; author reply 195. PubMed ID: 20653077
[No Abstract] [Full Text] [Related]
4. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to hepatic steatosis.
Diehl AM
N Engl J Med; 2010 Mar; 362(12):1142-3. PubMed ID: 20335592
[No Abstract] [Full Text] [Related]
6. Emerging genes associated with the progression of nonalcoholic fatty liver disease.
Koutsari C; Lazaridis KN
Hepatology; 2010 Sep; 52(3):807-10. PubMed ID: 20812353
[No Abstract] [Full Text] [Related]
7. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!
Chalasani N
Gastroenterology; 2009 Sep; 137(3):772-5. PubMed ID: 19638269
[No Abstract] [Full Text] [Related]
8. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
[TBL] [Abstract][Full Text] [Related]
9. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.
Bekri S; Gual P; Anty R; Luciani N; Dahman M; Ramesh B; Iannelli A; Staccini-Myx A; Casanova D; Ben Amor I; Saint-Paul MC; Huet PM; Sadoul JL; Gugenheim J; Srai SK; Tran A; Le Marchand-Brustel Y
Gastroenterology; 2006 Sep; 131(3):788-96. PubMed ID: 16952548
[TBL] [Abstract][Full Text] [Related]
10. Host genetic variants in obesity-related nonalcoholic fatty liver disease.
Mehta R; Birerdinc A; Younossi ZM
Clin Liver Dis; 2014 Feb; 18(1):249-67. PubMed ID: 24274878
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.
Oliveira CP; Stefano JT; Cavaleiro AM; Zanella Fortes MA; Vieira SM; Rodrigues Lima VM; Santos TE; Santos VN; de Azevedo Salgado AL; Parise ER; Ferreira Alves VA; Carrilho FJ; Corrêa-Giannella ML
J Gastroenterol Hepatol; 2010 Feb; 25(2):357-61. PubMed ID: 19817962
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.
Jun DW; Han JH; Jang EC; Kim SH; Kim SH; Jo YJ; Park YS; Chae JD
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):667-72. PubMed ID: 19262398
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
[TBL] [Abstract][Full Text] [Related]
15. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
[TBL] [Abstract][Full Text] [Related]
18. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
[TBL] [Abstract][Full Text] [Related]
19. Dietary conjugated linoleic acid induces tissue-specific lipoprotein lipase mRNA modulation in high-sucrose-fed mice.
Castellanos-Tapia L; Yepiz-Plasencia G; Moya-Camarenaa SY
Ann Nutr Metab; 2009; 54(2):131-7. PubMed ID: 19339774
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease.
Sookoian S; Castaño G; Gianotti TF; Gemma C; Rosselli MS; Pirola CJ
Cytokine; 2008 Oct; 44(1):201-6. PubMed ID: 18789715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
